| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |